OCX — Oncocyte Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Oncocyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	22.5	7.82	36.5	20.4	9.43
Net Total Accounts Receivable
Net Total Receivables	—	0.203	1.64	2.01	0.484
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	23	9.23	39.1	25.5	10.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.73	6.52	8.53	10.9	5.44
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	39.9	55.4	160	100	74.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.44	9	14.1	12.1	7.19
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9.02	21.9	94.3	60.5	49.3
Non Redeemable Preferred Stock
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	30.8	33.5	65.2	39.6	25.6
Total Liabilities & Shareholders' Equity	39.9	55.4	160	100	74.9
Total Common Shares Outstanding
Total Preferred Shares Outstanding